News and Events

Get all the latest information on upcoming events, press releases, and other news about CPL here

News

CPL’s Senior Manager of Formulations, Chetan Chure, in Pharmaceutical Technology Magazine

Chetan Chure was interviewed for the May 2022 issue of Pharmaceutical Technology Magazine for an article named Topical Formulations in Pharma-Balancing Form and Function regarding approaches and challenges to topical product manufacturing. To read the article, please go to: https://www.pharmtech.com/view/topical-formulations-in-pharma-balancing-form-and-function

News

CPL appoints Mallika Tushakiran as Director, Formulations

CPL is pleased to announce the promotion of Mallika Tushakiran to the position of Director, Formulations. Mallika joined CPL in 2012 as a Principal Scientist, Formulations and has held the position of Associate Director, Formulations since 2017. Cumulatively, Mallika has 30+ years of experience in product development of pharmaceutical dosage forms. This promotion acknowledges the […]

News

CPL Board Chair Caitlin Wege Profiled in DCAT’s Women Leaders in Pharma Interview Series

Caitlin Wege recently was interviewed by DCAT as part of their Women Leaders in Pharmaceutical Interview Series. Caitlin is Board Chair of CPL and its sister subsidiary, Glasshouse Pharmaceuticals. She is also a partner at MooDoos Investments, a private family-owned investment fund that invests in early-stage companies throughout the US and Canada. Caitlin is an […]

News

CPL appoints Brian Lankadurai as Director, Product Development Services

At CPL, our goal is to be the very best topical and non-sterile liquid CDMO in the world.  In order to be the best, we have built an experienced team of experts that can guide our customers’ products through the development, scale-up, and commercial manufacturing stages.  We are proud of our team and want to […]

News

CPL Completes Successful Virtual Health Canada Audit

June 2, 2021, Mississauga, Ontario, Canada— Contract Pharmaceuticals Limited Canada (CPL), a Health Canada and US FDA inspected manufacturer of liquid and semi-solid prescription and regulated OTC products, has successfully completed a virtual cGMP audit of its manufacturing facility by Health Canada. Since the onset of the global pandemic, CPL has focused on keeping our […]

News

CPL Launches Production of Hand-Sanitizer to Meet Critical Shortages

Mississauga, Ontario, Canada, April 9, 2020 — Contract Pharmaceuticals Limited Canada (CPL), a Health Canada and US FDA approved manufacturer of liquid and semi-solid prescription and OTC medicines, has begun production of its alcohol-based hand sanitizer to help meet the current market shortage during the ongoing COVID-19 pandemic. With the urgent need for hand sanitizer […]

News

CPL Introduces New Skin Lab for Topical Pharmaceutical Product Testing

Sujata Syam has been leading a group of scientists in building CPL’s newest service offering—testing of topical pharmaceutical products using skin-based technologies and approaches.  Sujata joined CPL in 2015 to head up the Skin Lab within the Product Development Services group.  Sujata has more than 20 years of experience in proteins, assay development and therapeutics. […]

News

CPL’s State-or-the-Art Commercial Manufacturing and Packaging Equipment

November 1, 2019–MISSISSAGUA, ONTARIO — CPL is a provider of pharmaceutical product development and commercial manufacturing services focused on non-sterile liquid and semi-solid dosage forms. In order to further establish itself as the leader in these dosage forms, the company’s Symex manufacturing vessels and new commercial filling lines for products packaged into tubes and bottles […]